One of the most important bioprocessing advances in recent years has been the rise in levels of manufactured therapeutic proteins. Indeed, the overall average yield reported for commercial monoclonal ...
Downstream Operations Can Relieve the Pressure of Higher Titers and Cell Densities without Undue Disruption Platform manufacturing keeps driving the industrialization of bioprocessing, both upstream ...
Argonaut’s Clinical Fill-Finish Capabilities to Complement Avid’s Upstream and Downstream Process Development and Biologics Manufacturing Services in Supporting Developers of Biologic Therapeutics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results